+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Eisai Co - logo

Eisai Limited is a research-based pharmaceutical company that develops, manufactures, and markets healthcare products for patients and their families. It offers products in the areas of Alzheimer's disease, gastrointestinal disorders, epilepsy, cervical dystonia, severe chronic pain, and oncology. The company was founded in 1988 and is based in Hatfield, United Kingdom. It also has operations in the United States, Asia, and Europe.

Nexavar (sorafenib; Bayer/Amgen) Drug Overview 2019 - Product Thumbnail Image

Nexavar (sorafenib; Bayer/Amgen) Drug Overview 2019

  • Report
  • September 2019
  • 28 pages
Humira - Product Thumbnail Image

Humira

  • Report
  • August 2018
  • 94 pages
From
From
From
Lenvima 2019 U.S. Promotional Audit Report - Product Thumbnail Image

Lenvima 2019 U.S. Promotional Audit Report

  • Report
  • July 2020
  • 24 pages
From
From
From
From
Thyroid Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Thyroid Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 1074 pages
From
Thyroid Cancer - Pipeline Insight, 2020 - Product Thumbnail Image

Thyroid Cancer - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 pages
From
Anaplastic Thyroid Cancer - Pipeline Insight, 2020 - Product Thumbnail Image

Anaplastic Thyroid Cancer - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 pages
From
From
Loading Indicator
adroll